US34965KAA51
© Globe Newswire
10.12.2025
FTRE
LISTED
NASDAQ
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
DURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on December 10, 2025, to two newly hired employees. The award consisted of 245,000 RSUs that vest in three equal annual inst...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
FTRE
LISTED
NASDAQ
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
News Preview
PRAGUE, Czech Republic and DURHAM, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global contract research organization (CRO), today announced a strategic collaboration agreement between the two companies. This partnership aims to streamline...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.11.2025
FTRE
LISTED
NASDAQ
Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences
News Preview
DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that chief executive officer, Anshul Thakral, chief financial officer, Jill McConnell, and senior vice president of investor relations, Tracy Krumme, will participate in the following conferences in Decemb...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
24.11.2025
FTRE
LISTED
NASDAQ
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
News Preview
DURHAM, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it has completed its debt tender offer (the “Tender Offer”) described in the Offer to Purchase dated October 20, 2025 by purchasing $75,743,000 in aggregate of the Company’s outstandin...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
05.11.2025
FTRE
LISTED
NASDAQ
Fortrea Reports Third Quarter 2025 Results
News Preview
For the three months ended September 30, 2025, from continuing operations:...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
FTRE
LISTED
NASDAQ
Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt
News Preview
DURHAM, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it has commenced a debt tender offer (the “Tender Offer”) to purchase for cash up to $75,744,000 (the “Maximum Amount”) in aggregate purchase price of the Company’s outstanding 7.500...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
FTRE
LISTED
NASDAQ
Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call
News Preview
DURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025. Fortrea will host a conference call at 8:00 am ET that day to review it...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
FTRE
LISTED
NASDAQ
Fortrea Appoints William Sharbaugh to Board of Directors
News Preview
DURHAM, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the appointment of William Sharbaugh to the Company’s Board of Directors. Mr. Sharbaugh brings extensive healthcare experience in finance, operations, manufacturing, and quality to the pos...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.09.2025
FTRE
LISTED
NASDAQ
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
DURHAM, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on September 12, 2025, to one newly hired employee. The award consisted of 75,000 RSUs that vest in three equal annual inst...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.07.2025
FTRE
LISTED
NASDAQ
Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call
News Preview
DURHAM, N.C., July 16, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2025 financial results before the market opens on Wednesday, August 6, 2025. Fortrea will host a conference call at 8:00 am ET that day to review its...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.06.2025
FTRE
LISTED
NASDAQ
Fortrea 与 Emery Pharma 宣布战略合作以开展符合 FDA 规范的利福平药物相互作用研究
News Preview
此次合作支持亚硝胺杂质检测，让申办方展示利福平在药物相互作用研究中的合理使用 此次合作支持亚硝胺杂质检测，让申办方展示利福平在药物相互作用研究中的合理使用...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.06.2025
FTRE
LISTED
NASDAQ
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
News Preview
Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
11.06.2025
FTRE
LISTED
NASDAQ
Fortrea Names Anshul Thakral Chief Executive Officer
News Preview
Thakral succeeds Interim CEO, Peter M. Neupert, who will remain chairman of the board Thakral succeeds Interim CEO, Peter M. Neupert, who will remain chairman of the board...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2025
FTRE
LISTED
NASDAQ
Fortrea to Present at the Jefferies Global Healthcare Conference
News Preview
DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 8:45...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.05.2025
FTRE
LISTED
NASDAQ
Fortrea Reports First Quarter 2025 Results
News Preview
For the three months ended March 31, 2025, from continuing operations:...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.05.2025
FTRE
LISTED
NASDAQ
Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025
News Preview
Recognized in both pre-and post-approval pharmacovigilance operations Recognized in both pre-and post-approval pharmacovigilance operations...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.04.2025
FTRE
LISTED
NASDAQ
Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call
News Preview
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2025 financial results before the market opens on Monday, May 12, 2025. Fortrea will host a conference call at 9:00 am ET that day to review its fina...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.03.2025
FTRE
LISTED
NASDAQ
Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance
News Preview
For the three months and full-year ended December 31, 2024, from continuing operations:...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.02.2025
FTRE
LISTED
NASDAQ
Society for Clinical Research Sites (SCRS) 联合 Fortrea 共同推进临床研究合作
News Preview
Fortrea 将赞助 SCRS 旗下 Collaborate Forward 工作组，鼓励加强协作、提高临床试验效率 Fortrea 将赞助 SCRS 旗下 Collaborate Forward 工作组，鼓励加强协作、提高临床试验效率...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.02.2025
FTRE
LISTED
NASDAQ
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
News Preview
Fortrea to Sponsor SCRS’ Collaborate Forward Working Group, Encouraging Collaboration for More Efficient Clinical Trials Fortrea to Sponsor SCRS’ Collaborate Forward Working Group, Encouraging Collaboration for More Efficient Clinical Trials...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.01.2025
FTRE
LISTED
NASDAQ
Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
News Preview
DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2024 financial results before the market opens on Monday, March 3, 2025. Fortrea will host a conference call at 9:00 am ET that day to...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2024
FTRE
LISTED
NASDAQ
Fortrea to Present at the Evercore HealthCONx Conference
News Preview
DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Evercore HealthCONx Conference on Thursday, December 5, 2024 at 10:00 am ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2024
FTRE
LISTED
NASDAQ
Fortrea to Present at the Citi Global Healthcare Conference
News Preview
DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Citi Global Healthcare Conference on Wednesday, December 4, 2024 at 1:45 pm ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2024
FTRE
LISTED
NASDAQ
Fortrea Reports Third Quarter 2024 Results
News Preview
For the three months ended September 30, 2024, from continuing operations:...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2024
FTRE
LISTED
NASDAQ
Fortrea publie son premier rapport de Responsabilité Sociale d’Entreprise
News Preview
DURHAM, Caroline du Nord, 18 oct. 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE), l’un des principaux organismes internationaux de recherche sous contrat (CRO), a annoncé aujourd’hui la publication du premier rapport de Responsabilité Sociale d’Entreprise de la société, « Fortrea for Better »....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2024
FTRE
LISTED
NASDAQ
Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call
News Preview
DURHAM, N.C., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it will release its third quarter 2024 financial results before the market opens on Friday, November 8, 2024. Fortrea will host a conference call at 8:00 am ET that day to review its...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.08.2024
FTRE
LISTED
NASDAQ
Fortrea Reports Second Quarter 2024 Results
News Preview
For the three months ended June 30, 2024, from continuing operations:...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.07.2024
FTRE
LISTED
NASDAQ
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
News Preview
DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Fortrea will host a conference call at 9:00 am ET that day to review its f...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.07.2024
FTRE
LISTED
NASDAQ
Fortrea Appoints Robert Parks as Chief Accounting Officer
News Preview
DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Robert “Bobby” Parks has been appointed as chief accounting officer (CAO), responsible for Fortrea’s accounting function, including financial reporting, risk, controls and compliance in accordance wit...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.06.2024
FTRE
LISTED
NASDAQ
Fortrea 推出 AI 创新工作室以整合技术和人力解决方案，改进临床试验交付
News Preview
北卡罗来纳州，达勒姆市, June 28, 2024 (GLOBE NEWSWIRE) -- 全球领先的合同研究组织 (CRO) Fortrea (Nasdaq: FTRE) 今天宣布推出人工智能 (AI) 创新工作室，标志着该公司在重塑当今及未来临床试验执行方面的战略投资。...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.06.2024
FTRE
LISTED
NASDAQ
Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
News Preview
DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will participate in a virtual fireside chat hosted by Elizabeth Anderson, senior managing director at Evercore ISI, to discuss Fortrea’s business on Thursday, Ju...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
FTRE
LISTED
NASDAQ
Fortrea Finaliza Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners
News Preview
DURHAM, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje que finalizou a alienação dos ativos relacionados ao seu segmento Enabling Services, ou seja, suas unidades Endpoint Clinical (“Endpoint”) e Fortrea Patient Access (“FPA”), para a Arsen...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
FTRE
LISTED
NASDAQ
Fortrea 已将 Endpoint Clinical 和 Patient Access 业务剥离给 Arsenal Capital Partners
News Preview
北卡罗来纳州，达勒姆市, June 05, 2024 (GLOBE NEWSWIRE) -- 全球领先的受托研究机构 (“CRO”) Fortrea (纳斯达克代码：FTRE) 今日宣布，已将旗下 Enabling Services 部门，即 Endpoint Clinical (“Endpoint”) 与 Fortrea Patient Access (“FPA”) 业务剥离给 Arsenal Capital Partners (“Arsenal”)，这是一家领先的私募股权公司，专注于打造市场领先的高科技医疗保健和产业发展公司。...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2024
FTRE
LISTED
NASDAQ
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
News Preview
DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2024
FTRE
LISTED
NASDAQ
Fortrea to Present at the Jefferies Global Healthcare Conference
News Preview
DURHAM, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
FTRE
LISTED
NASDAQ
Fortrea 推出改善临床研究中多样性和入选的综合解决方案
News Preview
利用真实世界数据、患者见解和系统化的流程，设计、实施和衡量临床试验中多样性行动计划的作用 利用真实世界数据、患者见解和系统化的流程，设计、实施和衡量临床试验中多样性行动计划的作用...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.05.2024
FTRE
LISTED
NASDAQ
Fortrea Appoints Machelle Sanders to Board of Directors
News Preview
DURHAM, N.C., May 16, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the appointment of Machelle Sanders to the Company’s Board of Directors. Ms. Sanders has served as North Carolina’s Secretary of Commerce since February 2021 and brings strong domain exper...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.05.2024
FTRE
LISTED
NASDAQ
Fortrea Reports First Quarter 2024 Results
News Preview
For the three months ended March 31, 2024, from continuing operations:...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.05.2024
FTRE
LISTED
NASDAQ
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
News Preview
DURHAM, N.C., May 06, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced an updated issuance date for the company’s first quarter 2024 financial results. The Company requires additional time to work through accounting and discontinued operations matters primarily...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
